首页> 外文期刊>BMC Public Health >Contraceptive use and method preference among HIV positive women in Addis Ababa, Ethiopia: a cross sectional survey
【24h】

Contraceptive use and method preference among HIV positive women in Addis Ababa, Ethiopia: a cross sectional survey

机译:埃塞俄比亚亚的斯亚贝巴的HIV阳性妇女的避孕药具使用和方法偏好:一项横断面调查

获取原文
           

摘要

Background Prevention of unplanned pregnancies among people living with HIV is essential component of “Global Plan” even in the context of expanded access to highly active antiretroviral therapy (HAART). The study aimed to assess whether contraceptive use and method preference varied by the use of HAART among HIV positive women in Addis Ababa, Ethiopia. Methods A cross sectional facility based survey was conducted from June to October, 2012 information was gathered using interviewer administered questionnaire and document review was conducted to confirm HIV status and clinical review. A sample of 1418 HIV positive women including 770 women receiving HAART and 648 HAART-na?ve recruited randomly from different health institutions in Addis Ababa. Data were principally analyzed using logistic regression. Result Overall, 71% women reported using contraception (75% among HAART users and 65% HAART na?ve women). Male condom and injectables are the most preferred contraceptive methods among both groups. The odds of contraceptive use among HAART users was higher (AOR 1.60, 95% CI; 1.30-2.12) than HAART na?ve women. In addition to this, presence of partner (AOR 2.32, 95% CI 1.60-3.40), disclosure of HIV status to husband (AOR 2.23; 95% CI 1.21-4.12), presence of living children: one (AOR 1.7; 95% CI 1.03-2.40), two (AOR 2.6; 95% CI 1.7-4.02) and three (AOR 3.3; 95% CI 1.90-5.60) respectively were found to be predictors of contraceptive use among HIV positive women. Conclusion The contraceptive profile of women in the study area mainly dependent on male condom use, this indicates the need to better integrate tailored counseling and contraceptive options with care and support activities that targets HIV positive women. Moreover, emphasis should be given to dual contraceptive method use along with their regular follow up irrespective of their HAART use.
机译:背景技术即使在扩大获得高效抗逆转录病毒疗法(HAART)的情况下,预防艾滋病毒感染者意外怀孕也是“全球计划”的重要组成部分。这项研究旨在评估埃塞俄比亚亚的斯亚贝巴的HIV阳性妇女在使用避孕药和使用避孕药方法方面是否有所不同。方法2012年6月至2012年10月进行横断面设施调查,使用访调员管理的问卷调查方法收集信息,并进行文件审查以确认HIV状况和临床审查。从亚的斯亚贝巴的不同卫生机构随机招募了1418名HIV阳性妇女,包括770名接受HAART的妇女和648例未接受HAART的妇女。数据主要使用逻辑回归分析。结果总体而言,有71%的妇女报告使用避孕措施(HAART使用者中有75%,HAART初次使用妇女中有65%)。男性避孕套和注射剂是两组中最优选的避孕方法。与单纯接受HAART的女性相比,使用HAART的女性使用避孕药具的几率更高(AOR 1.60,95%CI; 1.30-2.12)。除此之外,有伴侣(AOR 2.32,95%CI 1.60-3.40),向丈夫披露艾滋病毒状况(AOR 2.23; 95%CI 1.21-4.12),有活子女的存在:一名(AOR 1.7; 95% CI 1.03-2.40),两个(AOR 2.6; 95%CI 1.7-4.02)和三个(AOR 3.3; 95%CI 1.90-5.60)分别是HIV阳性女性避孕药的预测指标。结论研究区域妇女的避孕概况主要取决于男性避孕套的使用,这表明需要将针对性的咨询和避孕方案与针对艾滋病毒阳性妇女的护理和支持活动更好地结合起来。此外,无论是否使用HAART,都应重视双重避孕方法的使用以及常规随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号